SCHEMBL7811979

SCHEMBL7811979

CC1CCC2CN1CC2=O

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA4 P22748 1/20 0.32
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6417778 0.81 LMNA (0.32) CA1CA2CA4KMT2A
SCHEMBL4369964 0.68 SLC18A3 (0.30)
SCHEMBL17951103 0.61 SRD5A1 (0.31)
SCHEMBL19731524 0.61 YTHDF2 (0.32)
SCHEMBL7706452 0.61
SCHEMBL719728 0.61
SCHEMBL4009298 0.58
SCHEMBL7951217 0.58
SCHEMBL7947695 0.58
SCHEMBL10412631 0.58 ALDH1A1 (0.35) CA1CA2CA4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6281232-B1 AZABICYCLIC RING-SUBSTITUTED THIA- OR OXADIAZOLES NOVO NORDISK A/S (DK) 2001-08-28 US disclosed
US-6281233-B1 AZABICYCLIC RING-SUBSTITUTED THIA- OR OXADIAZOLES NOVO NORDISK A/S (DK) 2001-08-28 US disclosed
US-6271229-B1 ADMINISTERING A 1,2,5-OXADIAZOLE COMPOUND OR 1,2,5-THIADIAZOLE COMPOUND NOVO NORDISK A/S (DK) 2001-08-07 US disclosed
US-6265419-B1 IRRITABLE BOWEL DISORDER NOVO NORDISK A/S (DK) 2001-07-24 US disclosed
EP-0714394-B1 ANTIPSYCHOTIC METHOD WITH THIADIAZOLE AND OXADIAZOLE DERIVATIVES NOVO NORDISK AS (DK) 2001-06-20 EP disclosed
US-5968926-A SCHIZOPHRENIA TREATMENT WITH 1,2,5-OXADIAZOLE OR 1,2,5-THIADIAZOLE NOVO NORDISK A/S (DK) 1999-10-19 US disclosed
US-5663182-A ADMINISTERING AN AZABICYCLIC RING SUBSTITUTED THIADIAZOLE OR OXADIAZOLE TO A MAMMAL BYMASTER FRANKLIN PORTER (US) 1997-09-02 US disclosed
EP-0790995-A1 A METHOD OF TREATING URINARY BLADDER DYSFUNCTIONS NOVO NORDISK A/S (DK) 1997-08-27 EP disclosed
US-5641791-A USEFUL AS STIMULANTS OF COGNITIVE FUNCTION OF FOREBRAIN AND HIPPOCAMPUS OF MAMMALS AND IN THE TREATMENT OF ALZHIEMER'S DISEASE, SEVERE PAIN AND GLAUCOMA NOVO NORDISK A.S (DK) 1997-06-24 US disclosed
US-5612351-A AZABICYCLIC DERIVATIVES OF 1,2,3-OXA(OR THIA)DIAZOLE NOVO NORDISK A/S (DK) 1997-03-18 US disclosed
US-5578602-A FOR STIMULATING COGNITIVE FUNCTIONS OF THE BRAIN, TREATING ALZHEIMER*S DISEASE, GLAUCOMA OR PAIN NOVO NORDISK A/S (DK) 1996-11-26 US disclosed
US-5574043-A ALZHEIMERS, GLAUCOMA, ANALGESIC NOVO NORDISK A/S (DK) 1996-11-12 US disclosed
EP-0735869-A1 A METHOD OF TREATING GASTROINTESTINAL MOTILITY DISORDERS NOVO NORDISK A/S (DK) 1996-10-09 EP disclosed
US-5527813-A THERAPEUTICALLY ACTIVE AZABICYCLIC COMPOUNDS USEFUL AS STIMULANTS OF THE COGNITIVE FUNCTION OF THE FOREBRAIN AND IN THE TREATMENT OF ALZHEIMER'S DISEASE NOVO NORDISK A/S (DK) 1996-06-18 US disclosed
EP-0714394-A1 ANTIPSYCHOTIC METHOD NOVO NORDISK A/S (DK) 1996-06-05 EP disclosed
WO-1996014316-A1 A METHOD OF TREATING URINARY BLADDER DYSFUNCTIONS NOVO NORDISK A/S (DK) 1996-05-17 WO disclosed
EP-0687266-A1 HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1995-12-20 EP disclosed
WO-1995017180-A1 A METHOD OF TREATING GASTROINTESTINAL MOTILITY DISORDERS NOVO NORDISK A/S (DK) 1995-06-29 WO disclosed
WO-1995005379-A1 ANTIPSYCHOTIC METHOD NOVO NORDISK A/S (DK) 1995-02-23 WO disclosed
WO-1994020496-A1 HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1994-09-15 WO disclosed